Domesco Medical Import-Export JSC

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000DMC9
VND
58,000.00
-500 (-0.85%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
5,10,288.06
4,69,129.22
5,70,508.24
4,48,076.66
4,61,664.81
4,19,177.15
4,68,914.95
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
5,10,288.06
4,69,129.22
5,70,508.24
4,48,076.66
4,61,664.81
4,19,177.15
4,68,914.95
Raw Material Cost
4,25,154.98
3,73,041.05
4,30,102.55
3,75,170.65
3,55,030.40
3,21,642.95
3,60,751.10
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
40,328.23
40,577.88
0.00
38,279.46
38,148.72
42,700.19
41,565.73
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.14
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
44,274.61
48,667.76
46,772.52
45,188.46
45,899.97
53,590.97
47,394.31
Other Expenses
-4,032.82
-4,057.80
0.00
-3,827.95
-3,814.87
-4,270.02
-4,156.57
Total Expenditure (Excl Depreciation)
4,69,429.59
4,21,708.81
4,76,875.07
4,20,359.11
4,00,930.38
3,75,233.91
4,08,145.41
Operating Profit (PBDIT) excl Other Income
40858.5
47420.4
93633.2
27717.600000000002
60734.399999999994
43943.2
60769.5
Other Income
-1,188.92
11,384.51
2,482.41
13,274.78
4,384.43
7,276.89
11,538.96
Operating Profit (PBDIT)
44,449.30
63,480.58
1,00,559.75
45,346.15
69,286.18
55,584.17
76,908.68
Interest
0.00
0.14
0.00
0.00
0.00
0.00
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
85,133.08
96,088.17
1,40,405.70
72,906.01
1,06,634.41
97,534.20
1,08,163.85
Depreciation
4,779.75
4,675.66
4,444.16
4,353.83
4,167.32
4,364.04
4,600.18
Profit Before Tax
39,669.55
58,804.78
96,115.59
40,992.33
65,118.86
51,220.13
72,308.50
Tax
7,956.60
11,775.70
19,236.25
8,211.48
13,035.04
10,259.61
14,474.69
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
26,956.00
39,974.72
65,347.12
13,907.07
52,083.82
34,816.44
49,133.02
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
26,956.00
39,974.72
65,347.12
13,907.07
52,083.82
34,816.44
49,133.02
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
26,956.00
39,974.72
65,347.12
13,907.07
52,083.82
34,816.44
49,133.02
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
Reserves
15,68,585.26
16,59,596.98
16,12,567.90
15,35,686.42
15,02,905.58
15,61,473.70
15,20,513.18
Earnings per share (EPS)
776.22
1151.1
1881.71
400.46
1499.79
1002.56
1414.82
Diluted Earnings per share
776.22
1151.1
1881.71
400.46
1499.79
1002.56
1414.82
Operating Profit Margin (Excl OI)
8.01%
10.11%
16.41%
6.19%
13.16%
10.48%
12.96%
Gross Profit Margin
8.71%
13.53%
17.63%
10.12%
15.01%
13.26%
16.4%
PAT Margin
5.28%
8.52%
11.45%
3.1%
11.28%
8.31%
10.48%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 10.53% vs 15.49% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is -48.24% vs 9.17% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is -29.68% vs 25.09% in Jun 2024

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024

Compare Quarterly Results Of Domesco Medical Import-Export JSC With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(VND)
Change(%)
Net Sales
5,10,288.06
4,74,537.02
35,751.04
7.53%
Other Operating Income
0.00
0.00
0.00
Total Operating income
5,10,288.06
4,74,537.02
35,751.04
7.53%
Raw Material Cost
4,25,154.98
2,35,186.46
1,89,968.52
80.77%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
40,328.23
1,10,682.36
-70,354.13
-63.56%
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
785.04
-785.04
-100.00%
Selling and Distribution Expenses
44,274.61
1,36,884.91
-92,610.30
-67.66%
Other Expenses
-4,032.82
-11,146.74
7,113.92
63.82%
Total Expenditure (Excl Depreciation)
4,69,429.59
3,72,071.38
97,358.21
26.17%
Operating Profit (PBDIT) excl Other Income
40,858.47
102,465.64
-61,607.17
-60.12%
Other Income
-1,188.92
5,419.91
-6,608.83
-121.94%
Operating Profit (PBDIT)
44,449.30
1,21,005.79
-76,556.49
-63.27%
Interest
0.00
785.04
-785.04
-100.00%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
85,133.08
2,39,350.55
-1,54,217.47
-64.43%
Depreciation
4,779.75
13,120.24
-8,340.49
-63.57%
Profit Before Tax
39,669.55
1,07,100.52
-67,430.97
-62.96%
Tax
7,956.60
16,764.02
-8,807.42
-52.54%
Provisions and contingencies
0
0
0.00
Profit After Tax
26,956.00
90,336.50
-63,380.50
-70.16%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
26,956.00
90,336.50
-63,380.50
-70.16%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
26,956.00
90,336.50
-63,380.50
-70.16%
Equity Capital
0
0
0.00
Face Value
10,000.00
10,000.00
0.00
Reserves
15,68,585.26
16,38,930.91
-70,345.65
-4.29%
Earnings per share (EPS)
776.22
965.61
-189.39
-19.61%
Diluted Earnings per share
776.22
965.61
-189.39
-19.61%
Operating Profit Margin (Excl OI)
8.01%
21.59%
0.00
-13.58%
Gross Profit Margin
8.71%
25.33%
0.00
-16.62%
PAT Margin
5.28%
19.04%
0.00
-13.76%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 51,028.81 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 8.77% vs -17.77% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 10.53% vs 15.49% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 2,695.60 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -32.57% vs -38.83% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -48.24% vs 9.17% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4,563.82 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -12.40% vs -46.88% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -29.68% vs 25.09% in Jun 2024

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.01%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024